Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXF6PG
|
||||
| Drug Name |
(1-phenethylcyclobutyl)methyl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate
|
||||
| Synonyms |
CHEMBL184329
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C29H38N2O4
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)OCC1(CCc2ccccc2)CCC1)C(=O)C(=O)N[C@H](C)c3ccccc3
|
||||
| InChI |
InChI=1S/C29H38N2O4/c1-3-4-16-25(26(32)27(33)30-22(2)24-14-9-6-10-15-24)31-28(34)35-21-29(18-11-19-29)20-17-23-12-7-5-8-13-23/h5-10,12-15,22,25H,3-4,11,16-21H2,1-2H3,(H,30,33)(H,31,34)/t22-,25+/m1/s1
|
||||
| InChIKey |
ZFEZJCWWCISELK-RDGATRHJSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.